Concepedia

Ivan M. Robbins

IM

Statistics

Publications

87

Citations

12.5K

H-Index

52

Active since

1998

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

Duke Medical Center

University of California San Diego

Columbia University

Ivan M. Robbins is an author at Vanderbilt University Medical Center specializing in pulmonary hypertension, medicine, and pulmonology.

ORCID

Publications per year

1998–2023

87

Publications

87

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

David B. Badesch, Victor F. Tapson, Michael D. McGoon et al. · Annals of Internal Medicine · 2000 · 1.1K citations

, , +10

Sitaxsentan Therapy for Pulmonary Arterial Hypertension

Robyn J. Barst, David Langleben, Adaani Frost et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 707 citations

, , +17

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

Marc Humbert, Robyn J. Barst, Ivan M. Robbins et al. · European Respiratory Journal · 2004 · 641 citations · Full text

, , +12

Beraprost therapy for pulmonary arterial hypertension

Robyn J. Barst, Michael D. McGoon, Vallerie V. McLaughlin et al. · Journal of the American College of Cardiology · 2003 · 631 citations

, , +6

1–5 of 87